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Selective regulation of nuclear orphan receptors 4A by adenosine
receptor subtypes in human mast cells
Abstract
Nuclear orphan receptors 4A (NR4A) are early responsive genes that belong to the superfamily of
hormone receptors and comprise NR4A1, NR4A2 and NR4A3. They have been associated to
transcriptional activation of multiple genes involved in inflammation, apoptosis and cell cycle control.
Here, we establish a link between NR4As and adenosine, a paradoxical inflammatory molecule that can
contribute to persistence of inflammation or mediate inflammatory shutdown. Transcriptomics screening
of the human mast cell-line HMC-1 revealed a sharp induction of transcriptionally active NR4A2 and
NR4A3 by the adenosine analogue NECA. The concomitant treatment of NECA and the adenosine
receptor A(2A) (A(2A)AR) selective antagonist SCH-58261 exaggerated this effect, suggesting that
upregulation of these factors in mast cells is mediated by other AR subtypes (A(2B) and A(3)) and that
A(2A)AR activation counteracts NR4A2 and NR4A3 induction. In agreement with this,
A(2A)AR-silencing amplified NR4A induction by NECA. Interestingly, a similar A(2A)AR modulatory
effect was observed on ERK1/2 phosphorylation because A(2A)AR blockage exacerbated
NECA-mediated phosphorylation of ERK1/2. In addition, PKC or MEK1/2 inhibition prevented
ERK1/2 phosphorylation and antagonized AR-mediated induction of NR4A2 and NR4A3, suggesting
the involvement of these kinases in AR to NR4A signaling. Finally, we observed that selective
A(2A)AR activation with CGS-21680 blocked PMA-induced ERK1/2 phosphorylation and modulated
the overexpression of functional nuclear orphan receptors 4A. Taken together, these results establish a
novel PKC/ERK/nuclear orphan receptors 4A axis for adenosinergic signaling in mast cells, which can
be modulated by A(2A)AR activation, not only in the context of adenosine but of other mast cell
activating stimuli as well.
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Abstract  
Nuclear orphan receptors 4A (NR4A) are early responsive genes that belong 
to the superfamily of hormone receptors and comprise NR4A1, NR4A2 and 
NR4A3. They have been associated to transcriptional activation of multiple 
genes involved in inflammation, apoptosis and cell cycle control. Here, we 
establish a link between NR4As and adenosine, a paradoxical inflammatory 
molecule that can contribute to persistence of inflammation or mediate 
inflammatory shutdown. Transcriptomics screening of the human mast cell-
line HMC-1 revealed a sharp induction of transcriptionally active NR4A2 and 
NR4A3 by the adenosine analogue NECA. The concomitant treatment of 
NECA and the adenosine receptor A2A (A2AAR) selective antagonist SCH-
58261 exaggerated this effect, suggesting that upregulation of these factors in 
mast cells is mediated by other AR subtypes (A2B and A3) and that A2AAR 
activation counteracts NR4A2 and NR4A3 induction. In agreement with this, 
A2AAR-silencing amplified NR4A induction by NECA. Interestingly, a similar 
A2AAR modulatory effect was observed on ERK1/2 phosphorylation because 
A2AAR blockage exacerbated NECA-mediated phosphorylation of ERK1/2. In 
addition, PKC or MEK1/2 inhibition prevented ERK1/2 phosphorylation and 
antagonized AR-mediated induction of NR4A2 and NR4A3, suggesting the 
involvement of these kinases in AR to NR4A signaling. Finally, we observed 
that selective A2AAR activation with CGS-21680 blocked PMA-induced 
ERK1/2 phosphorylation and modulated the overexpression of functional 
nuclear orphan receptors 4A. Taken together, these results establish a novel 
PKC/ERK/nuclear orphan receptors 4A axis for adenosinergic signaling in 
mast cells, which can be modulated by A2AAR activation, not only in the 
context of adenosine but of other mast cell activating stimuli as well.  
 
Concise summary 
Non-selective AR engagement triggers robust induction NR4A orphan 
receptors in mast cells. Induction of these early responsive genes can be 
blocked by selective activation of the anti-inflammatory A2AAR not only in the 
context of adenosine but also of PMA signaling, suggesting a general 
mechanism of mast cell regulation. 
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Introduction 
NR4A orphan receptors are transcription factors that belong to the 
superfamily of steroid nuclear hormone receptors that have been associated 
with different cellular processes, including inflammation (Murphy et al. 2001; 
Pei et al. 2005), steroidogenesis (Manna et al. 2002), apoptosis (Winoto 
Littman 2002), development of dopaminergic neurons (Zetterstrom et al. 
1997) and glucose metabolism (Pei et al. 2006b). This subfamily of nuclear 
orphan receptors is constituted by 3 members: NR4A1 (also known as Nur77 
or nerve growth factor inducible B, NGFI-B), NR4A2 (also known as Nurr1) 
and NR4A3 (also known as NOR1). In the context of inflammation, these 
factors represent NF-κB and LPS-inducible genes in macrophages (Pei et al. 
2005) and NR4A1 expression leads to induction of inflammatory genes, 
potentiating NF-κB pro-inflammatory signaling by IKKi kinase upregulation 
(Pei et al. 2006a). In addition, NR4A2 has been recognized as an important 
inducible factor in inflamed synovium and as a target of anti-inflammatory 
effects of methotrexate (Ralph et al. 2005). 
Adenosine is a purine nucleoside normally present in the nanomolar range but 
its concentration in the extracellular space rises with increased oxygen 
consumption during hypoxia, tissue injury and inflammation. The rapid 
accumulation of adenosine is followed by biological responses through 
activation of 4 types of G-coupled adenosine receptors (ARs): A1, A2A, A2B 
and A3. Each of the receptor subtypes has a different pharmacological profile, 
tissue distribution and effector coupling profile. During chronic inflammatory 
processes the sustained formation of adenosine has been associated with 
deleterious effects. Elevated adenosine concentrations can be found, for 
example, in bronchoalveolar lavage and exhaled breath condesate of human 
patients with asthma (Driver et al. 1993; Huszar et al. 2002) where it 
perpetuates inflammation and contributes to airway hyperresponsiveness. 
However, activation of the A2AAR has been associated to the suppression of 
inflammation and tissue remodelling (Fozard 2003; Ohta Sitkovsky 2001) and 
inhibition of histamine and tryptase release from human mast cells (Suzuki et 
al. 1998). However, the transcriptional effectors downstream of AR activation 
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responsible for adenosine’s pro or anti-inflammatory effects remain to be 
characterized. 
In this study, we employed the human mast cell HMC-1 to characterize 
subtype specific effectors of AR activation and we established a link between 
adenosine receptor activation and nuclear orphan receptors. Furthermore, we 
determined that activation of the A2AAR counterbalances the induction of 
these transcription factors and that this effect is not limited to adenosinergic 
signaling but that it is also conserved for other mast cell activating stimuli. 
These observations describe a novel regulatory mechanism by A2AAR, with 
implications in the progression of inflammation and related pathologies.  
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Materials and methods 
 
Reagents and cell culture 
All chemicals were obtained from Sigma-Aldrich (Switzerland) unless 
otherwise indicated. The human mast cell line-1 (HMC-1) was a kind gift from 
Dr. J. H. Butterfield, Mayo Clinic, Rochester, MN, USA and was grown in 
Iscove's Modified Dulbecco's Medium (IMDM, Invitrogen) supplemented with 
10% iron supplemented fetal bovine serum (Invitrogen), 1.2mM 
alphathiglycerol (Sigma) and 100’000 U/l Penicillin and 100mg/l Streptomycin 
(complete IMDM) at 37°C in 5% CO2.  
 
Cell treatments 
HMC-1 cells were seeded at 8 x 105 cells/ml and allowed to settle overnight. 
They were then treated at the indicated concentrations with the following 
chemicals: the adenosine analogue NECA (5′-N-Ethylcarboxamido-
adenosine), the A2AAR agonist CGS-21680 (9-Chloro-2-(2-furanyl)-
[1,2,4]triazolo[1,5-c]quinazolin-5-amine), the A2AAR antagonist SCH-58261 (7-
(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-
c]pyrimidine) and PMA (phorbol 12-myristate 13-acetate). The length of 
treatment varied between 30 minutes and 72 hours. Cells were pretreated 
with 1 U/ml adenosine deaminase (Roche) to remove any pre-existing 
endogenous adenosine for 20 minutes.  
 
RNA extraction and cDNA synthesis 
Cells were collected by centrifugation at the corresponding time points and 
total RNA was recovered using the Qiashredder and Rneasy mini kit 
(Qiagen). Concentration and quality of total RNA were measured with the 
Ultraspec 2100 pro spectrophotometer (Amersham Biosciences). Samples 
with a UV absorbance 260/280 ratio of 1.8 to 2.1 were considered to be 
suitable for cDNA synthesis. RNA samples were stored at -20°C until use. 
Complementary DNA (cDNA) was synthesized using the one-cycle cDNA 
synthesis kit followed by a sample cleanup to optimize volumes and 
concentration of the cDNA (GeneChip sample cleanup module, Affymetrix). 
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Genome wide gene expression analysis 
Global gene expression analysis was done in 4 independent experiments, 
consisting of the treatment with 10 µM NECA and untreated cells as a 
baseline control. After 3h treatment of HMC-1 cells total RNA was extracted 
as described in the previous section. The quality of RNA was determined on 
the Agilent Lab-on-a-chip Bioanalyzer 2000 (Palo Alto, USA). Samples with a 
total area under 28S and 18S bands of less than 65% of total RNA, as well as 
a 28S/18S ratio of less than 1.5, were considered to be degraded and 
therefore excluded from microarray analysis. cRNA was synthesized from 
cDNA with the IVT labeling kit (Affymetrix). cRNA quality was assessed with 
the Agilent Lab-on-a-chip Bioanalyzer 2000. The biotin-labeled cRNA was 
fragmented and hybridized on Human Genome U122 plus 2.0 microarrays 
(Affymetrix), which cover sequences of 47’000 human transcripts, following 
the manufacturer’s instructions. After hybridization periods of 16 hours the 
microarrays were automatically washed and stained on the Affymetrix Fluidics 
Station 450. Staining of the hybridized probes was performed with fluorescent 
streptavidin-phycoerythrin conjugates (1 mg/ml; Molecular Probes). The 
subsequent scanning of DNA microarrays was carried out on an Affymetrix 
scanner 3000 7G. The generated data was then normalized and subsequently 
filtered using a significance value of P<0.05 using the GeneSpring 7.3.1 
sofware (Agilent, Palo Alto, CA, USA). We employed pair-wise analysis based 
on B - Fabric infrastructure tool (Functional Genomics Center Zurich, 
University of Zurich-Irchel, Switzerland) and the GeneGo Metacore 
(www.genego.com) integrated software for data mining and functional 
analysis of experimental data. Hierarchical clustering was performed with 
gplots library from CRAN. 
 
Real time polymerase chain reaction (RT-PCR) 
Specific primers for the selected transcripts as well as TaqMan probes and 
TaqMan master mix were obtained from Applied Biosystems. 40 ng of cDNA 
were mixed with 1µl of forward and reverse primers and 10 µl of master mix 
supplemented with 25nM of the corresponding TaqMan probe in a final 
volume of 20 µl. The reactions were performed in a 7500 Fast Real-time PCR-
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System ABI 7500 (Applied Biosystems) in 40 cycles (95 °C for 3 sec, 60 °C 
for 30 sec) after an initial 20 sec incubation at 95 °C, and was analyzed with 
the 7500 Fast System SDS Software System (Applied Biosystems). The fold 
change in expression of each gene was calculated with the 2-Delta Delta C(T) 
method. Each of these values had been normalized to the endogenous 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
 
Western blot 
30µg of total protein in 1x Laemmli buffer were separated on a 10% 
polyacrylamide gel by standard SDS-PAGE technique from each sample, 
followed by transfer onto Immune-Blot polyvinylidene difluoride (PVDF) 
membranes (0.2 µm pore size, Bio-Rad) and blocking 16 hours at 4°C with 
blocking solution (5% non-fat dry milk, 3% BSA in TBST (10mM Tris, 150 mM 
NaCl, 0.05% Tween 20, pH 7.4). NR4A2 and total ERK protein levels were 
assessed employing a monoclonal antibody (Alpha Diagnostic and  R&D, 
respectively) and phosphorylated ERK1/2 by a specific T185/Y187 phopsho-
antibody (R&D, USA). GAPDH and β-actin antibodies (Ambion, USA) were 
employed as internal loading controls. Enhanced chemiluminescence was 
performed with SuperSignal West Femto Maximum (Thermo Fisher Scientific, 
Switzerland) and images were acquired on a LAS-3000 image reader (Fujifilm 
Life Science, Japan). NR4A2 induction was quantified by calculating the ratio 
of intensity signals to GAPDH (Quantity 1 software, BioRad) and compared to 
untreated controls (value=1).     
 
siRNA silencing of A2AAR 
0.4 x 106 HMC-1 cells in 1ml were seeded in 24 well-plates. Cells were 
transcfected with 20nM A2AAR siRNA (Santa Cruz, Cat. sc-39850) using 4µl 
lipofectamine RNAiMax (Invitrogen) according to the manufacturer’s 
instructions in Opti-MEM serum and antibiotics-free medium. After 5h of 
incubation, the medium was replaced with complete medium. As a scramble 
negative control, control (FITC Conjugate)-A siRNA (Santa Cruz, sc-36869) 
was employed. Silencing of ARs was tested by RT-PCR with specific TaqMan 
probes (Applied Biosystems) as indicated above, and was maximal at 36h. 
Therefore, this time point was selected for further analysis of AR signaling. 
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Transient transfection and luciferase reporter gene assay 
1.5 x 106 HMC-1 cells in 1ml were co-transfected with the tk-NBREx3-luc 
plasmid, which was a kind gift Dr. R Evans (Howard Hughes Medical Institute, 
San Diego, CA) and the pRL-TK vector (Promega, USA) at a ratio 30:1 in 
serum- and antibiotics-free Iscove’s medium containing 8µl of Lipofectamine 
2000 reagent (Invitrogen). After 5 h of incubation, the medium was replaced 
with complete medium and were allowed to recover at 37°C for 24h and were 
subsequently stimulated as indicated. For luciferase activity assay, cell 
lysates were prepared and assayed using Luciferase Assay System 
(Promega, USA), according to the manufacturer’s instructions. All luminescent 
measurements were performed automatically in a 96 well-plate in a 
Luminescence Spectrometer (MLX, Dynex).  
 
 
Data analysis  
Statistical analysis was performed using the PASW Statistics software SPSS 
Inc., USA). Data were analyzed by nonparametric tests (Mann-Whitney U-test) 
and differences between groups were considered significant when p-values 
were less than 0.05.  
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Results 
Transcriptional profiling of human mast cells reveals upregulation of 
NR4A family memebers by adenosine receptor activation 
The human mast cell line HMC-1 exhibits a phenotype, which in several 
aspects is similar to tissue resident mast cells (Nilsson et al. 1994).  However, 
these cells do not degranulate and therefore represent a suitable system for 
studying degranulation-independent de novo synthesis of inflammatory 
mediators.   
Previous studies have successfully used this cell line to analyze adenosine 
signaling on human mast cells (Ryzhov et al. 2006; Ryzhov et al. 2004), which 
prompted us to employ a systematic genome-wide approach for the 
identification of novel effector molecules involved in AR signaling. For this, we 
stimulated HMC-1 cells to the adenosine analogue NECA and 3h after 
exposure the total fraction of RNA transcripts was extracted, processed and 
hybridized to Affymetrix microarrays (4 replicates). To identify differentially 
expressed genes, the data sets of each replicate were analysed in a pair-wise 
fashion with the untreated controls as described in the methods section. This 
analysis yielded 19 NECA-induced transcripts with fold changes of 3 or higher 
(table 1). The resulting heat map reflects the degree of similarity between the 
individual replicates (vertical dendogram, Fig 1A). Gene ontology analysis of 
these transcripts revealed that most of these transcripts encode protein 
products involved in transcription regulation (NR4A2, NR4A3, CREM , EGR1, 
2 and 3, FOSB, ELL2, ZEB1), signal transduction (HOMER1, ITK, IL2RB), 
hormone activity (STC1, CGA), DNA metabolism and repair (JMY, TP53INP2 
ITK), cell cycle regulation (RGC32), apoptosis (BCL2L11) and tissue 
remodeling (PLAUR). Remarkably, two nuclear orphan receptors (NR4A2 and 
NR4A3), which had not been associated to adenosine signaling before, were 
among the highest upregulated genes. Interestingly, the third member of 
orphan receptor family, NR4A1, was induced only marginally (2.05 fold). 
These results were confirmed by real time RT-PCR (Fig 1B) and suggest that 
NR4A2 and NR4A3 could mediate proinflammatory signaling by adenosine in 
mast cells.  
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A2AAR inactivation amplifies NECA-mediated induction of NR4A2 and 
NR4A3  
Human mast cells express A2A, A2B, and A3ARs (Feoktistov Biaggioni 1998; 
Feoktistov et al. 2003). Therefore, the observed response to NECA reflects 
the composite effect of activation of all 3 receptor subtypes. Because AR 
subtypes can promote (A2B and A3ARs) or downregulate (A2AAR) 
inflammation, we wanted to determine the influence of A2AAR in NR4A 
induction.  To address this issue cells were stimulated either with NECA, with 
the selective A2AAR agonist CGS-21680, or with a combination of NECA plus 
the A2AAR antagonist SCH-58261, and NR4A induction was assessed by RT-
PCR. Figures 2A and 2B show time-dependent induction of NR4A2 and 
NR4A3. While NECA-mediated induction of NR4A2 and NR4A3 reached 
maximal induction of 240-fold and 98-fold respectively 1h after treatment, 
selective activation of A2AAR with 1µM CGS-21680 did not induce them. In 
contrast, blockage of A2AAR with the combined treatment of NECA and SCH-
28261, results in further upregulation of these nuclear receptors, with fold 
changes up to 429 and 376 over the untreated controls respectively. These 
observations point out that the induction of these two transcription factors rely 
on the activation of non-A2A ARs. Interestingly, NECA plus SCH-58261 did not 
upregulate NR4A1 further when compared to NECA (4.2-fold, Fig 2C), 
indicating that this interplay between non-selective and selective A2AAR 
activation is not conserved to the third member of this family of receptors. 
Also, induction of the cAMP-response element modulator (CREM, a top-
regulated gene from the transcriptomics screening, see table 1) reaches 55-
fold when treated with NECA, while CGS-21680 or the combination of NECA 
plus SCH-58261 induce CREM only marginally, indicating that simultaneous 
activation of all ARs is required to achieve maximal CREM induction (Fig 2D). 
To confirm the role of A2AAR dependent changes in NR4A2 and NR4A3 
expression, HMC-1 cells were transfected with A2AAR-specific siRNA, which 
led to 63% silencing 36h after transfection (Fig 3A). Treatment of A2AAR 
silenced cells with NECA resulted in higher NR4A2 expression levels as 
compared to mock silenced cells, mimicking the effect of pharmacological 
blockage of A2AAR with the combination of NECA plus SCH-58261 (Fig 3B). 
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Altogether, these results indicate that activation of A2AAR counterbalances 
NR4A2 and NR4A3 induction by A2BAR and A3AR.  
 
Adenosine receptor activation increases NR4A2 protein abundance  
Next, we wanted to determine whether AR-mediated increment of NR4A2  
mRNA levels translate into changes in protein abundance. Western blot 
analysis of NR4A2 protein revealed that NECA treatment results in a 
remarkable induction of this factors reaching maximal levels at 12h, with 
values returning to background levels 24h after exposure (Fig4). As expected, 
selective A2AAR activation with CGS-21680 did not upregulate NR4A2 (not 
shown). However, induction of NR4A2 protein by the concomitant treatment of 
NECA plus SCH-58261 was higher than with NECA but also returned to basal 
levels within 24h. These results confirm that transcriptional upregulation of 
NR4A2 by AR activation results in increased protein levels.  
 
AR-induced NR4As are transcriptionally active  
In view of the strong induction of NR4A2 and NR4A3, we performed a 
functional assay based on an exogenous reporter gene to determine how the 
activity of these factors is affected by AR activation. NR4A receptors bind to 
the octanucleotide 5’-A/TAAAGGTCA (NGFI-B response element, NBRE) and 
therefore we employed an NBRE-luciferase reporter plasmid (tk-NBREx3-luc) 
and quantified luciferase induction upon AR activation. Fig 5 shows time-
dependent induction of luciferase activity upon treatment with NECA, CGS-
21680 or NECA in combination with SCH-58261. Both NECA and NECA plus 
SCH-58261 induced a robust response, which peaked between 12h and 24h 
with nearly a 30- and 40-fold reporter induction as compared to untreated 
controls respectively.  NBRE reporter activity decreased sharply by 48h and 
returned to background values 72h after treatment. On the contrary, CGS-
21680, did not induce luciferase expression significantly. Interestingly, 
reporter induction by NECA plus SCH-58261 was not statistically significantly 
higher than by NECA, despite the remarkable difference in induction of these 
transcription factors. This discrepancy can be explained by the intrinsic 
limitations of the artificial reporter gene system employed. The luciferase 
construct includes a minimal promoter region in the 5’-regulatory region of the 
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NBRE repeats. Therefore, this assay may not allow the full response (gene 
expression) that could be expected in the context of endogenous chromatin to 
take place, thereby limiting the amplitude of the responses measured and of 
the differences between treatments. Nevertheless, these results confirm that 
AR activation induces transcriptionally active NR4As that could have profound 
biological implications. 
 
AR-mediated NR4A2 and NR4A3 upregulation involves PKC and MEK 
kinases, and correlates with A2AAR-, PKC- and MEK-sensitive ERK1/2 
phosphorylation 
NR4As can be induced by a variety of stimuli, which are signaled through 
diverse intracellular regulators in a cell type and stimulus-dependent fashion 
(Martinez-Gonzalez Badimon 2005). Therefore, we wanted to determine the 
intracellular signaling pathways participating in NR4A2 and NR4A3 induction 
by ARs. To address this issue we interrogated the role of the mitogen-
activated kinase p38, protein kinase A (PKA), phosphoinositide 3 kinase 
(PI3K), protein kinase C (PKC) and MEK kinase with selective inhibitors, by 
assessing the AR-mediated induction of NR4A2 and NR4A3 (NECA plus 
SCH-58261). While 30 min pretreatment with SB203580 (p38 inhibitor), H89 
(PKA inhibitor) and wortmannin (PI3K inhibitor) did not affect NR4A induction, 
blockage of either PKC or MEK with GF109203X or PD98059 respectively 
partially reverted AR-mediated induction of these factors (Fig 6A).  Based on 
previous reports that showed that ERK phosphorylation is involved in AR 
inflammatory signaling in HMC-1 cells (Feoktistov et al. 1999), and because 
ERK1/2 is a downstream target of PKC, we wanted to determine whether 
activation of A2AAR correlates with ERK phosphorylation. NECA readily 
induced phosphorylation of ERK1/2 while CGS-21680 did not (Figure 6B, 
lanes 2 and 3). Interestingly, NECA plus SCH-58261 resulted in exaggerated 
ERK1/2 phosphorylation (lane 4), demonstrating an inverse relationship 
between A2AAR activation status and ERK1/2 phosphorylation. Furthermore, 
this pattern of ERK phosphorylation could be reverted by preincubation with 
GF109203X or with PD98059 in a concentration dependent manner (lanes 5 
to 8). Taken together, these results indicate that PKC and MEK kinases are 
required for AR-dependent ERK1/2 phosphorylation and NR4A2 and NR4A3 
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upregulation, and that activation of A2AAR opposes ERK1/2 activation by 
other ARs. 
 
A2AAR activation modulates PMA-induced ERK phosphorylation, NR4A2 
and NR4A3 induction and NBRE transcriptional activity  
Next, we wanted to assess whether A2AAR activation is able to influence 
NR4A induction by stimuli other than adenosine. Therefore, we selected PMA, 
a diester of phorbol that acts as a PKC activator, which is a central regulatory 
molecule with a role in cytokine production, arachidonic acid release and mast 
cell degranulation (Chang et al. 1997; Cho et al. 2004). Stimulation of HMC-1 
cells with PMA resulted in robust ERK1/2 phosphorylation that could be 
reverted with increasing concentrations CGS-21680 (Fig 7A). In addition, 1µM 
CGS-21680 significantly decreased PMA-mediated NR4A2 and NR4A3 
induction (by 35 and 53% respectively, Fig 7B) and, moreover, levels of PMA-
induced NR4A2 protein were also reduced (Fig 7C). In light of these findings, 
we tested whether A2AAR activation could affect the transcriptional activity of 
PMA-induced NR4As, by means of the NBRE-LUC reporter assay. 
Remarkably, preincubation with 1µM CGS-21680 caused a significant 
reduction in PMA-induced NBRE-LUC activity (35%, Fig 7D).  
Altogether, these results show that the inhibitory effect of A2AAR on nuclear 
orphan receptor 4A stimulation is conserved beyond adenosinergic 
inflammatory signaling and that activation of this receptor can regulate 
intracellular signaling by other inflammatory stimuli. 
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Discussion 
Mast cells have been traditionally associated to immediate-type 
hypersensitivity reactions through the release of preformed inflammatory 
mediators. However, in recent years it has become clear that these cells can 
regulate immune responses through de novo synthesis of cytokines, 
chemokines, and eicosanoids without degranulation (differential release 
inflammatory mediators), supporting a role of mast cells in more persistent 
(chronic) inflammatory and immunological responses such as chronic 
bronchitis and asthma-related pulmonary inflammation (Brightling et al. 2003; 
Church Levi-Schaffer 1997), renal injury (Mack Rosenkranz 2009), and 
tumorigenesis (Blatner et al. 2010; Groot Kormelink et al. 2009).  
The engagement of activating and inhibitory cell-surface receptors, as well as 
the intensity and duration of these signals, will determine the activation state 
of mast cells; in response to these stimuli, gene expression patterns of 
inflammatory mediators are altered according to the sum of positive and 
negative signaling events, thereby affecting the course of inflammation. Based 
on adenosine’s ability to both positively and negatively regulate mast cell 
activation through the engagement of alternate AR subtypes, it has been 
argued that selective activation of the A2AAR (anti-inflammatory) or blockage 
of A2BAR and A3AR (proinflammatory) may represent a pharmacological tool 
for modulating their adenosinergic inflammatory signaling. However, 
transcriptional effectors downstream of ARs responsible for adenosine’s pro- 
or anti-inflammatory effects remained to be fully characterized. 
In this study we present a novel link between AR activation and NR4A orphan 
receptors in human mast cells, and we show that selective activation of the 
A2AAR can negatively regulate the induction of these factors. Our initial 
genome-wide screening revealed strong upregulation of NR4A2 and NR4A3. 
Recent evidence shows that NR4A2 induction represents a common point of 
convergence of distinct cytokine signaling pathways, suggesting an important 
common role for this family of transcription factors as mediating inflammatory 
signaling (McEvoy et al. 2002). Therefore, we reasoned that the anti-
inflammatory A2AAR could influence the expression of these pro-inflammatory 
factors. In fact, we observed that the concomitant treatment with the A2AAR 
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antagonist SCH-58261 significantly amplified NECA’s effect on NR4A2 and 
NR4A3 induction. In view of the pleiotropic physiological roles of NR4As, 
adenosine’s effect on this group of transcription factors could have broad 
biological implications.  
In contrast to other members of the nuclear hormone receptor superfamily, 
the crystal structure and NMR data indicate that the ligand-binding pocket of 
NR4A receptors is covered by hydrophobic residues (Wang et al. 2003). In 
fact, these receptors have been shown to function as ligand-independent 
transcription factors that are constitutively active and whose activity is 
controlled at the level of protein expression and post-translational 
modifications (Codina et al. 2004; Fahrner et al. 1990). For this reason, 
adenosine’s effects on the abundance of these transcription factors could 
have immediate biological implications. On one hand, the activation of pro-
inflammatory ARs (i.e. A2B and A3ARs) in inflammatory cells could act as an 
amplification signal resulting in even higher levels of NR4As and in the 
expression of a larger set of NBRE-responsive genes. On the other, A2AAR 
activation could mediate inflammation resolution indirectly by limiting the 
expression of NR4A2 and NR4A3-dependent inflammatory genes.  
NR4As also influence the function of other inflammation-associated 
transcription factors. For example, NR4A1 and NR4A2 form heterodimers with 
retinoic acid receptor and can influence retinoid signaling (Wallen-Mackenzie 
et al. 2003). Therefore, AR activation could affect the number of NR4A-
containing complexes: AR-mediated accumulation of NR4A2 and NR4A3 
would translate in a higher proportion of transcriptional complexes containing 
these orphan receptors. Conversely, A2AAR activation would limit the 
availability of NR4A2 and NR4A3 for heterodimerization with other TFs. In 
addition, NR4A receptors can also crosstalk with other TFs and influence their 
activity without necessarily interacting with them. A recent study has 
established that NR4A receptors and the estrogen-related receptors NR3B 
mutually repress each others transcriptional activity (Lammi et al. 2007). 
Similarly, NR4A1 has been shown to negatively cross-talk with NF-κB (Harant 
Lindley 2004). As a consequence, by virtue of the induction of reamarkably 
high levels of functional NR4A2 and NR4A3, adenosine is likely profoundly 
affect the expression of large sets of genes both directly (NBRE-responsive 
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transcripts) and indirectly, by affecting the nature of transcriptional complexes 
and/or crosstalking with other TFs.  
Activation of mast cells (for example by the high affinity IgE receptor) requires 
the activation of receptor-proximal tyrosine kinases, mobilization of internal 
Ca2+ and the formation of signaling complexes coordinated by adaptor 
proteins (Rivera Gilfillan 2006). PI3K is a central player in mast cell activation 
that signals to regulatory molecules such as PKC and phospholipases C and 
D (PLC and PLD) among others, which ultimately regulate mast cell 
degranulation, arachidonic acid metabolite production and cytokine gene 
transcription. AR activation has traditionally been linked to stimulation or 
inhibition of the adenylyl cyclase; A2AAR and A2BAR activation lead to 
increased cAMP levels that in turn activate the canonical PKA pathway and 
the exchange protein directly activated by cAMP (Epac) (Palmer Trevethick 
2008), while A1AR and A3AR activation leads to cAMP decrease (Zhou et al. 
1992). In addition, AR signaling in mast cells has also been linked to PLC and 
calcium mobilization (A2BAR and A3AR), PI3K (A3AR), as well as PKC and 
MAP kinases (A1, A2A and A3AR) (Jacobson Gao 2006; Spicuzza et al. 2006).   
Several intracellular regulators have been linked to NR4A induction (Martinez-
Gonzalez Badimon 2005). In this study we established that AR-mediated 
NR4A2 and NR4A3 upregulation in HMC-1 did not involve PKA nor PI3K nor 
p38. Instead, PKC and MEK kinase inhibition could partially revert the 
induction of these factors and, moreover, the activity of these kinases 
correlated with ERK1/2 phosphorylation. Interestingly, some studies have also 
shown the involvement of ERKs in adenosine signaling (Feoktistov et al. 
1999) but downstream targets of ERK upon AR activation had remained 
elusive. The results presented here suggest that activation of ERK1/2 kinases 
downstream of PKC mediates NR4As induction by AR. Remarkably, A2AAR 
can counterbalance NECA-induced ERK1/2 phosphorylation, correlating with 
its modulatory effect on NR4A2 and NR4A3 induction. However, blockage of 
PKC and a complete inhibition of ERK phophorylation resulted only in about a 
50% decrease NR4A2 and NR4A3 induction, suggesting the involvement of at 
least one additional intracellular signaling pathway in AR-dependent nuclear 
orphan receptor upregulation in mast cells. The contribution of other 
intracellular signaling pathways remains to be investigated.  
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Finally, we examined whether the antagonistic effect of A2AAR on ERK1/2 
phosphorylation and NR4A2 and NR4A3 induction is preserved to other mast 
cell activating stimuli, by the concomitant activation of A2AAR and mast cell 
stimulation with PMA. Strikingly, A2AAR engagement resulted not only in a 
modulation of PMA-mediated ERK1/2 phosphorylation, but also limited 
NR4A2 and NR4A3 induction, and their activity as assessed by the NBRE-
LUC reporter assay. These results show that A2AAR modulatory’s effect on 
the ERK1/2-NR4A signaling axis is not limited to adenosinergic signaling.  
Taken together, the results presented in this study establish a novel effector 
signaling axis downstream of adenosine, and suggest NR4A antagonism as a 
mechanism mediating A2AAR anti-inflammatory effects in mast cells. Thus, 
this data contributes to the understanding of how receptor-specific signals are 
integrated towards modulation of the inflammatory response, which could 
facilitate the development of AR-based strategies of immunomodulation.  
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Figure legends 
Fig. 1. (A) Hierarchical clustering analysis of transcriptional changes of HMC-
1 cells induced by NECA. Each column represents a single experiment (4 
replicates for each condition, untreated and treated with 10µMNECA, 3h) and 
contains all genes that were significantly upregulated in at least one of 
replicates and a minimum induction of 3 fold. The resulting vertical 
dendrogram indicates the degree of similarity between different 
transcriptomes. Expression levels are expressed in a log 2 scale and 
transcripts with values of 5 or lower (blue and light blue) are marginally 
expressed or absent. Repeated gene names indicate different probe sets for a 
single gene (different expression signals for alternative probe sets could 
indicate alternative splicing or poor probe performance). (B) Confirmation of 
NR4A induction by RT-PCR. Fold changes are calculated in relation to 
untreated controls. Values represent the mean of three experiments ± SEM. 
 
 
Fig. 2. Time dependent induction of NR4A2 (A), NR4A3 (B), NR4A1 (C) and 
CREM (D). Cells were treated with 10µM NECA, 1µM CGS-21680 (CGS) or 
10µM  NECA plus 1 µM SCH-58261 (SCH) and RNA was collected at the 
indicated time points and analyzed by RT-PCR. Fold changes are calculated 
against untreated controls. Values represent the mean of three independent 
experiments ± SEM.  
 
Fig. 3. Effect of A2AAR silencing on NR4A2 induction. (A) Transfection of 
HMC-1 cells with A2AAR-siRNA (A2AAR si) specifically downregules this 
receptor subtypeation of A2AAR. Scramble siRNA was included as a control 
(B) A2AAR silenced cells were treated with for 2h with 10µM of NECA or 10µM 
of NECA plus 1 µM SCH-58261 (SCH). Values represent the mean of three 
independent experiments ± SEM. 
 
Fig. 4. Western blot analysis of NR4A2. HMC-1 cells were treated with 10µM 
NECA, or the combination of 10µM NECA and 1 µM SCH-58261 (SCH) for 
the indicated time points. GAPDH is included as an internal control. Fold 
change of NR4A2 protein (FC) are calculated from the ratio to GAPDH and 
compared to baseline expression in untreated cells (lane 1).  
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Fig. 5. Time-dependent induction of NBRE by AR engagement. The results 
are shown as ratio against the respective untreated control. For each 
measurement the ratio between the reporter gene (firefly) between and the 
internal Renilla standard was calculated (three independent determinations). 
Cells were treated with 10µM NECA, 1µM CGS-21680 (CGS) or 10µM  NECA 
plus 1 µM SCH-58261 (SCH).  
 
 
Fig. 6. Effect of kinase inhibitors on AR-mediated NR4A induction and ERK1/2 
activation (A) Pretreatment with MEK and PKC inhibitors partially reversed 
NR4A2 and NR4A3 induction by 10µM NECA and 1µM SCH-58261. 0.5µM 
SB203580 (SB), 1µM H89, 0.1µM wortmannin (Wt), 100µM PD98059 (PD) or 
10µM GF109203X (GF) were employed for preincubation. (B) A2AAR-
blockage excacerbates NECA-induced phosphorylation of ERK1/2 (N+SCH). 
This effect is blocked by preincubation with PD98059 (PD) and GF109203X 
(GF) in a concentration dependent way.   
 
Fig. 7. Effect of A2AAR activation on PMA-mediated NR4A activity. (A) 
Increasing concentrations of CGS-21680 (CGS) antagonize PMA-induced 
ERK1/2 phosphorylation. β-Actin is included as an internal control, (B) 
Reduction of PMA-mediated NR4A2 and NR4A3 transcriptional induction by 
increasing concentrations of CGS-21680 (CGS). Values are relative to 
induction by PMA and indicate the mean of three independent experiments ± 
SEM. *, **: p <0.05 for reduction in NR4A2 and NR4A3 induction respectively 
(Mann-Whitney U test), (C) Western blot analysis of NR4A2 induced by PMA 
alone or with the indicated concentrations of CGS-21680, (D) CGS-21680 
(CGS) reduces the transcriptional activity of PMA-mediated NBRE-LUC 
reporter activity. For each measurement the ratio between the reporter gene 
(firefly) and the internal Renilla standard was calculated. Values are relative to 
LUC expression by PMA, and represent the mean of three independent 
experiments ± SEM. PMA concentration in all experiments was 50nM. 
*p<0.05 for NBRE-LUC activity reduction (Mann-Whitney U test). 
 
 
 
Table 1. Top regulated transcripts by non-selective AR stimulation. Cells were 
treated with 10µM NECA and fold changes (FC) calculated against untreated 
control as described (fold change cut-off=3, P<0.005). 
   
Gene Name Description NECA FC 
NR4A2 Nuclear receptor subfamily 4, group A, member 2 33.52 
STC1 Stanniocalcin 1 25.37 
NR4A3 Nuclear receptor subfamily 4, group A, member 3 24.13 
CREM CAMP responsive element modulator 13.57 
EGR3 Early growth response 3 10.16 
RGC32 Response gene to complement 32 9.54 
HOMER1 Homer homolog 1 (Drosophila) 7.95 
FOSB FBJ murine osteosarcoma viral oncogene homolog B 6.91 
CGA Glycoprotein hormones, alpha polypeptide 6.14 
ELL2 Elongation factor, RNA polymerase II, 2 6.14 
JMY Junction-mediating and regulatory protein 5.96 
ZEB1 Transcription factor 8  5.42 
EGR1 Early growth response 1 5.07 
BCL2L11 BCL2-like 11 (apoptosis facilitator) 4.99 
ITK IL2-inducible T-cell kinase 4.76 
PLAUR Plasminogen activator, urokinase receptor 4.58 
TP53INP2 p53 induced nuclear protein 2 3.88 
IL2RB Interleukin 2 receptor, beta 3.78 
EGR2 Early growth response 2 (Krox-20 homolog, Drosophila) 3.72 







